Finance

Lists
Why is 688189 down 2,08%?
Dive Deeper
688189:SHA
Hunan Nucien Pharmaceutical Co Ltd
CNÂ¥6,13
-2,08%
(-0,13) 1D
15 Okt., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688189...
Open
CNÂ¥6,10
High
CNÂ¥6,20
Low
CNÂ¥6,10
Mkt. cap
1,73 mjd
Avg. vol.
2,58 m
Volume
2,50 m
52-wk high
CNÂ¥11,39
52-wk low
CNÂ¥5,47
EPS
-CNÂ¥0,49
No. of employees
277
Open
CNÂ¥6,10
High
CNÂ¥6,20
Low
CNÂ¥6,10
Mkt. cap
1,73 mjd
Avg. vol.
2,58 m
Volume
2,50 m
52-wk high
CNÂ¥11,39
52-wk low
CNÂ¥5,47
EPS
-CNÂ¥0,49
No. of employees
277
News stories
From web sources and news partners
About Hunan Nucien Pharmaceutical Co Ltd
CEO-
Employees277
Founded27 Des. 2006
Headquarters-
SectorPharmaceutical industry
Websitenucien.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
21,31 m
58,77 m
26,05 m
30,00 m
Cost of goods sold
15,23 m
49,37 m
19,48 m
30,46 m
Cost of revenue
15,23 m
49,37 m
19,48 m
30,46 m
Research and development expenses
9,75 m
8,06 m
4,26 m
4,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,19 m
30,68 m
13,80 m
16,21 m
Operating expense
30,42 m
39,20 m
22,16 m
23,45 m
Total operating expenses
45,65 m
88,57 m
41,64 m
53,91 m
Operating income
-24,34 m
-29,79 m
-15,59 m
-23,92 m
Other non operating income
-10,75 k
-2,72 k
-21,28 k
-1,08 m
EBT including unusual items
-32,15 m
-56,63 m
-15,11 m
-25,89 m
EBT excluding unusual items
-24,40 m
-30,86 m
-15,44 m
-24,79 m
Income tax expense
-198,91 k
17,35 m
-307,42 k
-7,54 k
Effective tax rate
0,62%
-30,64%
2,03%
0,03%
Other operating expenses
528,72 k
-264,59 k
265,52 k
879,18 k
Net income
-28,63 m
-68,27 m
-13,24 m
-23,92 m
Net profit margin
-134,37%
-116,15%
-50,84%
-79,74%
Earnings per share
-
-
-
-
Interest and investment income
732,68 k
291,91 k
217,65 k
277,48 k
Interest expense
-774,80 k
-1,35 m
-44,87 k
-65,33 k
Net interest expenses
-42,12 k
-1,06 m
172,78 k
212,15 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,25 m
-21,10 m
-6,90 m
-16,70 m
Gain or loss from assets sale
-
-2,53 m
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme